Top

Published in:

01-12-2008 | Journal club critique

Procalcitonin-guided antibiotics in severe sepsis

Authors: Peter Simon, Eric B Milbrandt, Lillian L Emlet

Published in: Critical Care | Issue 6/2008

Excerpt

Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J: Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008, 177: 498–505 [1]. …

Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J: Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2008, 177: 498-505. 10.1164/rccm.200708-1238OC.CrossRefPubMed

Meisner M: Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta. 2002, 323: 17-29. 10.1016/S0009-8981(02)00101-8.CrossRefPubMed

Al Nawas B, Krammer I, Shah PM: Procalcitonin in diagnosis of severe infections. Eur J Med Res. 1996, 1: 331-333.PubMed

Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993, 341: 515-518. 10.1016/0140-6736(93)90277-N.CrossRefPubMed

Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L: Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004, 8: R234-R242. 10.1186/cc2877.PubMedCentralCrossRefPubMed

Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R: Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000, 28: 977-983. 10.1097/00003246-200004000-00011.CrossRefPubMed

Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R: Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med. 2000, 26 (Suppl 2): S148-S152.CrossRefPubMed

Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, Periat P, Bucher HC, Christ-Crain M: Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med. 2008, 168: 2000-2007. 10.1001/archinte.168.18.2000.CrossRefPubMed

Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004, 363: 600-607. 10.1016/S0140-6736(04)15591-8.CrossRefPubMed

10.

Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Muller B: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med. 2006, 174: 84-93. 10.1164/rccm.200512-1922OC.CrossRefPubMed

11.

Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W: Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med. 2000, 28: 950-957. 10.1097/00003246-200004000-00007.CrossRefPubMed

12.

Christ-Crain M, Muller B: Procalcitonin in bacterial infections – hype, hope, more or less?. Swiss Med Wkly. 2005, 135: 451-460.PubMed

13.

Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA: Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med. 2007, 50: 34-41. 10.1016/j.annemergmed.2006.10.020.CrossRefPubMed

14.

Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006, 34: 1996-2003. 10.1097/01.CCM.0000226413.54364.36.CrossRefPubMed

15.

Tang BM, Eslick GD, Craig JC, McLean AS: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007, 7: 210-217. 10.1016/S1473-3099(07)70052-X.CrossRefPubMed

16.

Bone RC, Sibbald WJ, Sprung CL: The ACCP-SCCM consensus conference on sepsis and organ failure. Chest. 1992, 101: 1481-1483. 10.1378/chest.101.6.1481.CrossRefPubMed

17.

PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA). Accessed October 26, 2008., [http://clinicaltrials.gov/ct2/show/NCT00472667]

18.

The Procalcitonin and Survival Study (PASS). Accessed October 26, 2008., [http://clinicaltrials.gov/ct2/show/NCT00271752]

19.

Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection. Accessed October 26, 2008., [http://clinicaltrials.gov/ct2/show/NCT00407147]

Title: Procalcitonin-guided antibiotics in severe sepsis
Authors: Peter Simon
Eric B Milbrandt
Lillian L Emlet
Publication date: 01-12-2008
Publisher: BioMed Central
Published in: Critical Care / Issue 6/2008
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc7124

At a glance: The STEP trials

Springer Medicine

Procalcitonin-guided antibiotics in severe sepsis

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2008

End-expiratory lung volume during mechanical ventilation: a comparison with reference values and the effect of positive end-expiratory pressure in intensive care unit patients with different lung conditions

Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis

Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients

Clinical review: Critical care management of spontaneous intracerebral hemorrhage

Clinical review: Critical illness polyneuropathy and myopathy

Renal haemodynamic, microcirculatory, metabolic and histopathological responses to peritonitis-induced septic shock in pigs